Oncology Pharma Renews Licensing Agreement With Ribera Solutions LLC for Its Connect2Med Clinical Trials Platform
San Francisco, CA, Feb. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma Inc. (OTC: ONPH) is pleased to announce...
News
Milestone Scientific Continues Expansion of Distributor Network for Dental Instrument in the US; Adds Two Additional Independent Distributors Covering Atlanta and Tennessee
Adds four independent U.S. distributors in under one month ROSELAND, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc....
Allogene Therapeutics Announces Participation in Four Upcoming Virtual Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
NXT-ID Reduces Term Debt by $5.0 Million
Oxford, Connecticut, Feb. 09, 2021 (GLOBE NEWSWIRE) -- NXT-ID, Inc. (“NXTD” or the “Company”) (NASDAQ: NXTD), a provider of healthcare...
THC Therapeutics Has Begun the Process of Acquiring A Significant Amount of Physical Silver Bullion
The company has leveraged the Founder & Chairman’s network to acquire physical silver at a very low premium above spot...
Better Choice Announces $2.0 Million Stock Repurchase Program
NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice”), an animal health and wellness...
OpGen, Inc. Announces $25 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules
GAITHERSBURG, Md., Feb. 09, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power...
Rubius Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results
CAMBRIDGE, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is using its...
Scapa Healthcare Enhances Manufacturing & Innovation Capabilities at its Knoxville, TN Center of Excellence
To Support New Product Development of Custom Skin Fixation and Topical Solutions for Wound Care, Wearable Medical Devices and Healthcare...
Whole Health Pharmacy Partners to Launch Avricore’s HealthTab™
VANCOUVER, British Columbia, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”)...
Daré Bioscience to Present at the 2021 BIO CEO & Investor Digital Conference
SAN DIEGO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced...
electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Reduce Ileus After Major Colorectal Surgery
ROCKAWAY, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication...
Equillium Announces the Appointment of Katherine Xu to the Board of Directors
LA JOLLA, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to...
aTyr Pharma to Present at BIO CEO & Investor Digital Conference
SAN DIEGO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery...
Strong ULT Freezer Orders for First Month of 2021 for Reflect Scientific Inc.
OREM, Utah, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
Galecto to Present at Upcoming Investor Conferences
BOSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biotechnology company focused on the development of novel treatments...
AREV Appoints Dr. Roscoe Moore to Join the Advisory Board
VANCOUVER, British Columbia, Feb. 09, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Brands”) is...
NGM Bio Announces Upcoming Oral Presentation of Phase 1 Study of NGM621 in Patients with Geographic Atrophy at Angiogenesis, Exudation, and Degeneration 2021 – Virtual Edition
--Humanized IgG1 monoclonal antibody engineered to potently inhibit complement C3, with the potential for extended every eight-week dosing-- --CATALINA Phase...
Avicanna Enters Multi-level Strategic Partnership with Al Harrington’s, Harrington Wellness Inc., to Commercialize re+PLAY™ Branded Products in Canada and the United States
Avicanna Enters Multi-level Strategic Partnership with Al Harrington’s, Harrington Wellness Inc., to Commercialize re+PLAY™ Branded Products in Canada and the...
Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors
WARREN, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and...